PLIA2_CERGO
ID PLIA2_CERGO Reviewed; 166 AA.
AC P0DQP8;
DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT 02-JUN-2021, sequence version 1.
DT 25-MAY-2022, entry version 4.
DE RecName: Full=Phospholipase A2 inhibitor CgMIP-II {ECO:0000303|PubMed:10698689};
DE AltName: Full=Myotoxin inhibitor protein II of C.godmani {ECO:0000303|PubMed:10698689};
DE Short=CgMIP-II {ECO:0000303|PubMed:10698689};
DE AltName: Full=alpha-PLI;
DE Flags: Precursor;
OS Cerrophidion godmani (Porthidium godmani) (Bothrops godmani).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC Serpentes; Colubroidea; Viperidae; Crotalinae; Cerrophidion.
OX NCBI_TaxID=44722;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 20-46, SUBCELLULAR
RP LOCATION, AND GLYCOSYLATION.
RC TISSUE=Liver, and Plasma;
RX PubMed=10698689; DOI=10.1042/bj3460631;
RA Lizano S., Angulo Y., Lomonte B., Fox J.W., Lambeau G., Lazdunski M.,
RA Gutierrez J.M.;
RT "Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops)
RT godmani which selectively inhibit two different group-II phospholipase A2
RT myotoxins from its own venom: isolation, molecular cloning and biological
RT properties.";
RL Biochem. J. 346:631-639(2000).
CC -!- FUNCTION: Selectively inhibits the toxic properties of myotoxin-II from
CC the same venom (AC P81165) (PubMed:10698689). Does not inhibit PLA2,
CC anti-coagulant and lethal activities of the basic myotoxin I from the
CC same venom (AC P0DQP6), nor the different crotoxin forms (heterodimer
CC or subunit B alone) (PubMed:10698689). Does not block the enzymatic
CC activity of crude acidic PLA2 fractions from the same venom
CC (PubMed:10698689). {ECO:0000269|PubMed:10698689}.
CC -!- SUBUNIT: Homomer composed of 20-25-kDa subunits that form oligomers of
CC 180 kDa. {ECO:0000269|PubMed:10698689}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P21755}.
CC Note=Secreted in plasma. {ECO:0000250|UniProtKB:P21755}.
CC -!- TISSUE SPECIFICITY: Expressed by the liver.
CC {ECO:0000250|UniProtKB:P21755}.
CC -!- PTM: N-glycosylated. The glycosidic chain may contain superficial
CC sialic acid residues. {ECO:0000269|PubMed:10698689}.
CC -!- SIMILARITY: Belongs to the alpha-type phospholipase A2 inhibitor
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DQP8; -.
DR SMR; P0DQP8; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR GO; GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW.
DR Gene3D; 3.10.100.10; -; 1.
DR InterPro; IPR001304; C-type_lectin-like.
DR InterPro; IPR016186; C-type_lectin-like/link_sf.
DR InterPro; IPR018378; C-type_lectin_CS.
DR InterPro; IPR016187; CTDL_fold.
DR Pfam; PF00059; Lectin_C; 1.
DR SUPFAM; SSF56436; SSF56436; 1.
DR PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Disulfide bond; Glycoprotein; Lectin;
KW Phospholipase A2 inhibitor; Secreted; Signal.
FT SIGNAL 1..19
FT /evidence="ECO:0000269|PubMed:10698689"
FT CHAIN 20..166
FT /note="Phospholipase A2 inhibitor CgMIP-II"
FT /evidence="ECO:0000305|PubMed:10698689"
FT /id="PRO_0000452706"
FT DOMAIN 46..161
FT /note="C-type lectin"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT CARBOHYD 122
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000250|UniProtKB:P21755"
FT DISULFID 83..160
FT /evidence="ECO:0000250|UniProtKB:P21755"
FT DISULFID 138..152
FT /evidence="ECO:0000250|UniProtKB:P21755"
FT CONFLICT 42..43
FT /note="DF -> HV (in Ref. 1; AA sequence)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 166 AA; 18282 MW; 815410F26F79480C CRC64;
MRLILLSGLL LLGTFLANGD EKDSEIQLLN SMIEAVMILQ RDFSNLRYAL MTVHNARSFG
SGSERVYVSN KEVSKFEGLE EICSQAGGHI PSPQLENQNK AFADVLERHN KAAYLVVGDS
ANFTNWAAGH PNEADGTCVK ADTHGSWHSA SCDDNLLVVC EFYFIL